• Skip to main content
  • Skip to main content
Choose which site to search.
University of Arkansas for Medical Sciences Logo University of Arkansas for Medical Sciences
Research and Innovation: Office of Research Regulatory Affairs
  • UAMS Health
  • Jobs
  • Giving
  • Regulatory Affairs
    • ClinicalTrials.gov Registration
    • Good Tissue Practice
    • ORRA Monitoring Unit
      • Study Monitoring
      • Study Management Tools
        • Adverse Event Log (Device)
        • Adverse Event Log (Drug)
        • Compensation Log
        • Concomitant Medication Log
        • Delegation of Authority Log
        • Deviation Log
        • Device Accountability Log
        • Device Accountability Log (Use)
        • Eligibility Checklist
        • IND – IDE Monitoring Plan
        • Informed Consent Process Note
        • Regulatory Binder Contents
        • Role of the Medical Monitor
        • Screening-Enrollment Log
        • SIV Agenda
        • Source Data Agreement
        • Specimen Tracking Log
    • ORRA Regulatory Unit
      • Investigational Device Exemption Submission
      • Investigational New Drug Submission
  • Resources For Investigators
    • Research Resources
    • Useful Links
  • Research Policies
  • Contact
  • Staff Listing
  1. University of Arkansas for Medical Sciences
  2. Research and Innovation
  3. Office of Research Regulatory Affairs
  4. Research-Regulatory Affairs News

Research-Regulatory Affairs News

Failure to Report: A STAT Investigation on ClinicalTrials.gov

Stanford University, Memorial Sloan Kettering Cancer Center, and other prestigious medical research institutions have flagrantly violated a federal law requiring public reporting of study results, depriving patients and doctors of complete data to gauge the safety and benefits of treatments, a STAT investigation has found. The violations have left gaping holes in a federal database […]

Filed Under: Research-Regulatory Affairs News

Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring

Reliable approaches to monitoring are critical, and although a variety of monitoring approaches are available for overseeing clinical trial conduct, the most common approach remains frequent visits to each clinical trial site. During the past two decades, there has been a dramatic global increase in the number and complexity of clinical trials. In 2013, the […]

Filed Under: Research-Regulatory Affairs News

GCPartner App Now Available

The new GCPartner app is now the must have app for all researchers involved in Good Clinical Practices (GCPs).    Have the  GCP’s at your finger tips no matter where you are at.  For more information on how to get this free app click here…..

Filed Under: Research-Regulatory Affairs News

FDA Issues Guidance on Laboratory Developed Tests (LDT’s)

Laboratory developed test (LDT) is a type of in vitro diagnostic test that is designed, manufactured and used within a single laboratory. LDTs can be used to measure or detect a wide variety of analytes (substances such as proteins, chemical compounds like glucose or cholesterol, or DNA), in a sample taken from a human body. […]

Filed Under: Research-Regulatory Affairs News

University of Arkansas for Medical Sciences LogoUniversity of Arkansas for Medical SciencesUniversity of Arkansas for Medical Sciences
Mailing Address: 4301 West Markham Street, Little Rock, AR 72205
Phone: (501) 686-7000
  • Facebook
  • X
  • Instagram
  • YouTube
  • LinkedIn
  • Pinterest
  • Disclaimer
  • Terms of Use
  • Privacy Statement
  • Legal Notices

© 2026 University of Arkansas for Medical Sciences